APA (7th ed.) Citation

SE, S., KD, M., P, P., R, A., F, F., JW, M., . . . LH, E. (2002). Combined anti-microtubule therapy: A phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 13(10), 1612. https://doi.org/10.1093/annonc/mdf283

Chicago Style (17th ed.) Citation

SE, Soule, Miller KD, Porcu P, Ansari R, Fata F, McClean JW, Zon R, Sledge GW, and Einhorn LH. "Combined Anti-microtubule Therapy: A Phase II Study of Weekly Docetaxel Plus Estramustine in Patients with Metastatic Breast Cancer." Annals of Oncology : Official Journal of the European Society for Medical Oncology 13, no. 10 (2002): 1612. https://doi.org/10.1093/annonc/mdf283.

MLA (9th ed.) Citation

SE, Soule, et al. "Combined Anti-microtubule Therapy: A Phase II Study of Weekly Docetaxel Plus Estramustine in Patients with Metastatic Breast Cancer." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 13, no. 10, 2002, p. 1612, https://doi.org/10.1093/annonc/mdf283.